Drug Shortages

iSpeak Blog
The individual stories of patients—and their families—are welcome reminders to the pharmaceutical industry about just how meaningful pharmaceutical development, manufacturing, and delivery are every day to those patients and their families.
Special Reports
When faced with large-scale disruptive events such as the COVID-19 pandemic, the emergency and business continuity plans of drug manufacturers and event-specific actions of health authorities may not always be sufficient to prevent shortages of critical medical products. However, early, transparent...
iSpeak Blog
ISPE places the health and safety of its members, staff, and the broader ISPE global community as its top priority. As the COVID-19 outbreak continues, the ISPE Drug Shortages Initiatives Team encourages everyone to follow the available safety and health...
Features
In the 1960s, almost all children diagnosed with the most common pediatric cancer, acute lymphoblastic leukemia (ALL), were dead within 5 years. The steady and dramatic rise in survival rates since then means that today these kids have a near-90% chance...
Features
After much focus at recent conferences and in publications on understanding the manufacturing- and quality-related causes of drug shortages, delegates at the 2016 ISPE Annual Meeting & Expo in Atlanta, Georgia, had the opportunity to hear from a panel of...
Training
The prevention of drug shortages is critically important to public health. As a not-for-profit global organization with both industry and regulatory members in 90 countries, ISPE is uniquely positioned to facilitate...
None
For nearly a decade, ISPE and a task force of industry leaders have been working on ways to better understand the root causes and possible mitigations for drug shortages. ISPE has engaged leaders from more than 30 major...
iSpeak Blog
General Session On Drug Shortages Reveals Progress article is featured in the July/August 2016 issue of Pharmaceutical Engineering® Magazine to be published this month. Drug shortages were the topic of the General Session on Day 1 of the ISPE/FDA/PQRI...
iSpeak Blog
Tuesday afternoon also saw an education session on drug shortages, led by Diane L. Hustead, Associate Director, Regulatory Affairs, Merck & Co. Inc. She introduced the two speakers and explained that each presentation would be followed by a Q&A...